Replies to post #181963 on Biotech Values

[DewDiligence]

1) Yes. 2) For ACST, the eligibility requirement wrt triglycerides for the trial in question is [200-877mg/dL] (http://www.clinicaltrials.gov/ct2/show/NCT01455844 ); the 200-500 portion of this range is where there could be a problem. (As you already know, AMRN’s Vascepa is FDA-approved for treating patients with TG>=500mg/dL.)